login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ADIAL PHARMACEUTICALS INC (ADIL) Stock News
USA
- NASDAQ:ADIL -
US00688A2050
-
Common Stock
0.3457
USD
0 (-1.28%)
Last: 10/30/2025, 11:29:05 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADIL Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Benzinga
- Mentions:
IVA
PMI
GNTA
ARMP
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
13 days ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
21 days ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
a month ago - By: Benzinga
- Mentions:
SMTC
FCX
FIS
CELH
This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
a month ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
2 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
2 months ago - By: Zacks Investment Research
All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy
2 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
3 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
4 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
4 months ago - By: Yahoo Finance
- Mentions:
TMO
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4
4 months ago - By: Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
Please enable JavaScript to continue using this application.